Pulmonary hypertension not a major feature of early mixed connective tissue disease: A prospective clinicoserological study

Journal of Postgraduate Medicine

Volumn 51, Issue 2, 2005, Pages 104-107

  Haroon, N ^a   Nisha, R S ^a   Chandran, V ^a   Bharadwaj, A ^a  

^a KASTURBA MEDICAL COLLEGE   (India)

Author keywords

Interstitial lung disease; Lupus; Myositis; Overlap syndrome; Scleroderma

Indexed keywords

ANTINUCLEAR ANTIBODY;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DYSPHAGIA; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HUMAN; IMMUNOASSAY; INDIA; INFLAMMATION; INTERSTITIAL LUNG DISEASE; KIDNEY DISEASE; LABORATORY TEST; LUNG FUNCTION TEST; MALE; MIGRAINE; MIXED CONNECTIVE TISSUE DISEASE; MYOSITIS; ONSET AGE; POLYARTHRITIS; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; SCHIRMER TEST; SEROLOGY; SJOEGREN SYNDROME;

ADULT; ANTIBODIES; ARTHRITIS; EDEMA; FEMALE; FINGERS; HUMANS; HYPERTENSION, PULMONARY; INDIA; MALE; MIXED CONNECTIVE TISSUE DISEASE; PROSPECTIVE STUDIES; RAYNAUD DISEASE;

EID: 22144468747     PISSN: 00223859     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective issue disease: An apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen. Am J Med 1972;52:148-59.
2. Hassfeld W, Steiner G, Studnicka-Benke A, Skriner K, Graninger W, Fischer I, et al. Autoimmune response to the spliceosome. An immunologic link between rheumatoid arthritis, mixed connective tissue disease and systemic lupus erythematosus. Arthritis Rheum 1995;38:777-85.
3. Sharp PA. Splicing of messenger RNA precursors. Science 1987;235:766-71.
4. Newman A. RNA splicing. Activity in the spliceosome. Curr Biol 1994;4:462-4.
5. Hoffman RW, Greidinger EL. Mixed connective tissue disease. Curr Opin Rheumatol 2000;12:386-90.
6. Pettersson I, Wang G, Smith EI, Wigzell H, Hedfors E, Horn J, et al. The use of immunoblotting and immunoprecipitation of (U) small nuclear ribonucleoproteins in the analysis of sera of patients with mixed connective tissue disease and systemic lupus erythematosus: a cross-sectional, longitudinal study. Arthritis Rheum 1986;29:986-96.
7. Sharp GC, Irvin WS, May CM, Holman HR, McDuffie FC, Hess EV, et al. Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective tissue diseases, systematic lupus erythematosus and other rheumatic diseases. N Engl J Med 1976;295:1149-54.
8. Citera G, Lazaro MA, Maldonado Cocco JA. Mixed connective tissue disease: fact or fiction? Lupus 1995;4:255-7.
9. Isenberg D, Black C. Naming names! Comment on article by Smolen and Steiner. Arthritis Rheum 1999;42:191-6.
10. Smolen JS, Steiner G. Mixed connective tissue disease: to be or not to be? Arthritis Rheum 1998;41:768-77.
11. McHugh N, James I, Maddison P. Clinical significance of antibodies to a 68 kd U1 RNP polypeptide in connective tissue diseases. J Rheum 1990;17: 1320-8.
12. Nimelstein SH, Brody S, McShane D, Holman HR. Mixed connective tissue disease: a subsequent evaluation of the original 25 patients. Medicine (Baltimore) 1980;59:239-48.
13. Bodolay E, Gaal J, Vegh J, Soltesz P, Szodoray P, Lakos G, et al. Evaluation of survival in mixed connective tissue disease (MCTD). Orv Hetil. 2002;143:2543-8.
14. Sullivan WD, Hurst DJ, Harmon CE, Esther JH, Agia GA, Maltby JD, et al. A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease. Medicine 1984;63:92-107.
15. Jones MB, Osterholm RK, Wilson RB, Martin FH, Commers JR, Bachmayer JD. Fatal pulmonary hypertension and resolving immune-complex glomerulonephritis in mixed connective tissue disease. A case report and review of the literature. Am J Med 1978;65:855-63.
16. Fagan KA, Badesch DB. Pulmonary hypertension associated with connective tissue disease. Prog Cardiovasc Dis 2002;45:225-34.
17. Okawa-Takatsuji M, Aotsuka S, Fujinami M, Uwatoko S, Kinoshita M, Sumiya M. Up-regulation of intercellular adhesion molecule-1 (ICAM-1), endothelial leucocyte adhesion molecule-1 (ELAM-1) and class II MHC molecules on pulmonary artery endothelial cells by antibodies against U1-ribonucleoprotein. Clin Exp Immunol 1999;116:174-80.
18. Okawa-Takatsuji M, Aotsuka S, Uwatoko S, Takaono M, Iwasaki K, Kinoshita M, et al. Endothelial cell-binding activity of anti-U1-ribonucleoprotein antibodies in patients with connective tissue diseases. Clin Exp Immunol 2001;126:345-54.
19. Bodolay E, Csipo I, Gal I, Sipka S, Gyimesi E, Szekanecz Z, et al. Anti-endothelial cell antibodies in mixed connective tissue disease: frequency and association with clinical symptoms. Clin Exp Rheumatol. 2004;22:409-15.
20. Sood A, Kumar A, Pande I, Malaviya AN. Does mixed connective tissue disease exist in India? Br J Rheumatol 1995;34:539-41.
21. Nedumaran, Rajendran CP, Porkodi R, Parthiban R. Mixed connective tissue disease-clinical and immunological profile. J Assoc Physicians India 2001;49:412-4.
22. Soriano ER, McHugh NJ. Overlap syndromes in adults and children. In Issenberg DA, Maddison PJ, Woo P, Glass D and Breedveld FC (Editors.): Oxford textbook of rheumatology (3rd Edn.). Oxford:OUP; 2004, p.
23. Gendi NS, Welsh KI, van Venrooij WJ, Vancheeswaran R, Gilroy J, Black CM. HLA type as a predictor of mixed connective tissue disease differentiation. Ten year clinical and immunogenetic follow up of 46 patients. Arthritis Rheum 1995;38:259-66.
24. Burdt MA, Hoffman RW, Deutscher SL, Wang GS, Johnson JC, Sharp GC. Long-term outcome in mixed connective tissue disease. Longitudinal Clinical and Serologic Findings. Arthritis Rheum 1999;42:899-909.
25. Hoffman RW, Cassidy JT, Takeda Y, Smith-Jones EI, Wang GS, Sharp GC. U1-70kd Autoantibody-positive mixed connective tissue disease in children. A longitudinal clinical and serological analysis. Arthritis Rheum 1993;36:1599-602.
26. Setty YN, Pittman CB, Mahale AS, Greidinger EL, Hoffman RW. Sicca symptoms and Anti-SSA/Ro antibodies are common in Mixed Connective Tissue Disease. J Rheumatol 2002;29:487-9.
27. de Rooij DJ, Habets WJ, van de Putte LB, Hoet MH, Verbeek AL, van Venrooij WJ. Use of recombinant RNP peptides 70K and A in an ELISA for measurement of antibodies in mixed connective tissue disease: a longitudinal follow up of 18 patients. Ann Rheum Dis 1990;49:391-5.